KEGG   PATHWAY: btax04932
Entry
btax04932                   Pathway                                
Name
Non-alcoholic fatty liver disease - Budorcas taxicolor (takin)
Description
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum ranging from simple steatosis to more severe steatohepatitis with hepatic inflammation and fibrosis, known as nonalcoholic steatohepatitis (NASH). NASH may further lead to cirrhosis and hepatocellular carcinoma (HCC). This map shows a stage-dependent progression of NAFLD. In the first stage of NAFLD, excess lipid accumulation has been demonstrated. The main cause is the induction of insulin resistance, which leads to a defect in insulin suppression of free fatty acids (FAAs) disposal. In addition, two transcription factors, SREBP-1c and PPAR-alpha, activate key enzymes of lipogenesis and increase the synthesis of FAAs in liver. In the second stage, as a consequence of the progression to NASH, the production of reactive oxygen species (ROS) is enhanced due to oxidation stress through mitochondrial beta-oxidation of fatty acids and endoplamic reticulum (ER) stress, leading to lipid peroxidation. The lipid peroxidation can further cause the production of cytokines (Fas ligand, TNF-alpha, IL-8 and TGF), promoting cell death, inflammation and fibrosis. The activation of JNK, which is induced by ER stress, TNF-alpha and FAAs, is also associated with NAFLD progression. Increased JNK promotes cytokine production and initiation of HCC.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
btax04932  Non-alcoholic fatty liver disease
btax04932

Disease
H01333  Non-alcoholic fatty liver disease
Organism
Budorcas taxicolor (takin) [GN:btax]
Gene
128043191  NDUFAB1; acyl carrier protein, mitochondrial [KO:K03955]
128043200  NDUFB10; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 [KO:K03966]
128043457  [KO:K02266]
128043471  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
128043818  PRKAG3; 5'-AMP-activated protein kinase subunit gamma-3 isoform X1 [KO:K07200]
128043889  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
128044425  PKLR; pyruvate kinase PKLR [KO:K12406] [EC:2.7.1.40]
128044447  JUN; transcription factor Jun [KO:K04448]
128044474  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
128044487  NDUFS2; NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial [KO:K03935] [EC:7.1.1.2]
128044580  PRKAA2; 5'-AMP-activated protein kinase catalytic subunit alpha-2 [KO:K07198] [EC:2.7.11.31]
128044593  SDHC; succinate dehydrogenase cytochrome b560 subunit, mitochondrial isoform X1 [KO:K00236]
128044635  NDUFA10; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial [KO:K03954]
128045003  [KO:K00416]
128045108  PRKAB2; 5'-AMP-activated protein kinase subunit beta-2 [KO:K07199]
128045118  NDUFV3; NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial isoform X1 [KO:K03944]
128045154  NDUFS5; NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 [KO:K03938]
128045230  LEPR; leptin receptor [KO:K05062]
128045475  [KO:K00416]
128045517  IL6R; interleukin-6 receptor subunit alpha [KO:K05055]
128045803  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
128046227  [KO:K08738]
128046252  PRKAG2; 5'-AMP-activated protein kinase subunit gamma-2 [KO:K07200]
128046403  NDUFA5; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 [KO:K03949]
128046617  LEP; leptin [KO:K05424]
128046653  NDUFB5; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial [KO:K03961]
128046696  NDUFA4; cytochrome c oxidase subunit NDUFA4 [KO:K03948]
128046897  [KO:K00416]
128046952  IL6; interleukin-6 [KO:K05405]
128046972  NDUFB2; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial [KO:K03958]
128046973  [KO:K03947]
128047244  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
128047285  DDIT3; DNA damage-inducible transcript 3 protein [KO:K04452]
128047346  ADIPOR2; adiponectin receptor protein 2 [KO:K07297]
128047426  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
128047601  PPARA; peroxisome proliferator-activated receptor alpha [KO:K07294]
128047668  TNFRSF1A; tumor necrosis factor receptor superfamily member 1A isoform X1 [KO:K03158]
128047836  NDUFA9; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial [KO:K03953]
128047885  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
128047923  BID; BH3-interacting domain death agonist [KO:K04726]
128048350  [KO:K04374]
128048376  NDUFA12; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 [KO:K11352]
128048391  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
128048517  NDUFA6; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 [KO:K03950]
128048621  NDUFA4L2; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 [KO:K03948]
128048702  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
128048815  PRKAG1; 5'-AMP-activated protein kinase subunit gamma-1 isoform X1 [KO:K07200]
128049417  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
128049619  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
128049958  CXCL8; interleukin-8 [KO:K10030]
128050313  INSR; insulin receptor isoform X1 [KO:K04527] [EC:2.7.10.1]
128050328  [KO:K00236]
128050540  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
128050721  NDUFA2; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 [KO:K03946]
128050799  NDUFS7; NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial [KO:K03940] [EC:7.1.1.2]
128051202  NDUFB7; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 [KO:K03963]
128051330  NDUFA7; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 [KO:K03951]
128051389  NDUFA13; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 [KO:K11353]
128051423  [KO:K00418]
128051437  NDUFA11; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 [KO:K03956]
128051495  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
128052403  NDUFB6; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 [KO:K03962]
128053214  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
128053423  [KO:K02270]
128053787  NDUFB4; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 [KO:K03960]
128053843  [KO:K08738]
128053924  [KO:K08738]
128053951  FOS; protein c-Fos [KO:K04379]
128054019  [KO:K08738]
128054117  EIF2S1; eukaryotic translation initiation factor 2 subunit 1 [KO:K03237]
128054757  [KO:K00411] [EC:7.1.1.8]
128055294  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
128055401  BCL2L11; bcl-2-like protein 11 isoform X1 [KO:K16341]
128055475  TRAF2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
128055801  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
128055900  [KO:K00237]
128056100  ADIPOQ; adiponectin [KO:K07296]
128056132  [KO:K02265]
128056168  NDUFA8; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 [KO:K03952]
128056188  [KO:K02270]
128056196  EIF2AK3; eukaryotic translation initiation factor 2-alpha kinase 3 [KO:K08860] [EC:2.7.11.1]
128056569  IL1B; interleukin-1 beta [KO:K04519]
128056679  IL1A; interleukin-1 alpha [KO:K04383]
128056772  TNF; tumor necrosis factor [KO:K03156]
128056978  RXRA; retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
128057660  IRS2; LOW QUALITY PROTEIN: insulin receptor substrate 2 [KO:K07187]
128058489  [KO:K03943] [EC:7.1.1.2]
128058730  [KO:K02263]
128058832  ITCH; E3 ubiquitin-protein ligase Itchy homolog isoform X1 [KO:K05632] [EC:2.3.2.26]
128059229  [KO:K00417]
128059268  NDUFB9; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 [KO:K03965]
128059285  [KO:K00413]
128060079  SDHD; succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial [KO:K00237]
128060120  NDUFS3; NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial [KO:K03936] [EC:7.1.1.2]
128060316  NR1H3; oxysterols receptor LXR-alpha isoform X1 [KO:K08536]
128061187  ADIPOR1; adiponectin receptor protein 1 [KO:K07297]
128061491  AKT3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
128061812  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
128061813  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
128061956  MLXIPL; carbohydrate-responsive element-binding protein [KO:K09113]
128062051  PRKAB1; 5'-AMP-activated protein kinase subunit beta-1 [KO:K07199]
128062194  [KO:K00237]
128062235  XBP1; LOW QUALITY PROTEIN: X-box-binding protein 1 [KO:K09027]
128062389  MLXIP; MLX-interacting protein [KO:K09113]
128062396  [KO:K02266]
128062454  NDUFC1; NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial [KO:K03967]
128063056  NDUFA3; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 [KO:K03947]
128063106  [KO:K02263]
128063107  [KO:K00411] [EC:7.1.1.8]
128063162  GSK3A; glycogen synthase kinase-3 alpha [KO:K08822] [EC:2.7.11.26]
128063320  TGFB1; transforming growth factor beta-1 proprotein [KO:K13375]
128063483  [KO:K02267]
128063561  NDUFS1; NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial [KO:K03934] [EC:7.1.1.2]
128063570  [KO:K02267]
128063622  [KO:K02270]
128063714  [KO:K00415]
128063870  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
128063910  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
128064207  BAX; apoptosis regulator BAX [KO:K02159]
128064556  MLX; max-like protein X isoform X1 [KO:K09113]
128064658  ERN1; serine/threonine-protein kinase/endoribonuclease IRE1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]
128064715  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]
128064775  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
128065352  SREBF1; sterol regulatory element-binding protein 1 [KO:K07197]
128065926  PRKAA1; 5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X1 [KO:K07198] [EC:2.7.11.31]
128065950  [KO:K00414]
128066111  NDUFS4; NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial [KO:K03937]
128066127  NDUFS6; NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial [KO:K03939]
128066232  SDHA; succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial [KO:K00234] [EC:1.3.5.1]
128066235  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha [KO:K02649]
128066401  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
128066743  [KO:K02264]
128066874  NDUFB1; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 [KO:K03957]
128067048  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
128067418  NDUFV2; NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial [KO:K03943] [EC:7.1.1.2]
128067718  CASP7; caspase-7 isoform X1 [KO:K04397] [EC:3.4.22.60]
128067819  NDUFB8; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial [KO:K03964]
128067868  NDUFB3; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 isoform X1 [KO:K03959]
128067871  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
128067945  [KO:K07415] [EC:1.14.14.-]
128068238  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
128068336  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
128068546  RELA; transcription factor p65 [KO:K04735]
128068660  NDUFV1; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial [KO:K03942] [EC:7.1.1.2]
128068699  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
128068819  NDUFS8; NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial isoform X1 [KO:K03941] [EC:7.1.1.2]
128068963  NDUFC2; NADH dehydrogenase [ubiquinone] 1 subunit C2 [KO:K03968]
128069000  IRS1; insulin receptor substrate 1 [KO:K16172]
128069029  SDHB; succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial isoform X1 [KO:K00235] [EC:1.3.5.1]
128069202  MAP3K11; mitogen-activated protein kinase kinase kinase 11 [KO:K04419] [EC:2.7.11.25]
128069208  INS; insulin [KO:K04526]
128069489  [KO:K08738]
128070083  [KO:K02271]
128070595  NDUFB11; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial [KO:K11351]
128071326  [KO:K02270]
8250962  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]
8250963  COX2; cytochrome c oxidase subunit II [KO:K02261]
8250966  COX3; cytochrome c oxidase subunit III [KO:K02262]
8250972  CYTB; cytochrome b [KO:K00412]
Compound
C00031  D-Glucose
C00162  Fatty acid
Reference
  Authors
Naik A, Kosir R, Rozman D
  Title
Genomic aspects of NAFLD pathogenesis.
  Journal
Genomics 102:84-95 (2013)
DOI:10.1016/j.ygeno.2013.03.007
Reference
  Authors
Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L
  Title
Molecular mechanisms involved in NAFLD progression.
  Journal
J Mol Med (Berl) 87:679-95 (2009)
DOI:10.1007/s00109-009-0464-1
Reference
  Authors
Seki E, Brenner DA, Karin M
  Title
A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.
  Journal
Gastroenterology 143:307-20 (2012)
DOI:10.1053/j.gastro.2012.06.004
Reference
  Authors
Tilg H, Moschen AR
  Title
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.
  Journal
Hepatology 52:1836-46 (2010)
DOI:10.1002/hep.24001
Reference
  Authors
Larter CZ, Farrell GC
  Title
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
  Journal
J Hepatol 44:253-61 (2006)
DOI:10.1016/j.jhep.2005.11.030
Reference
  Authors
Farrell GC, van Rooyen D, Gan L, Chitturi S
  Title
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.
  Journal
Gut Liver 6:149-71 (2012)
DOI:10.5009/gnl.2012.6.2.149
Reference
  Authors
Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P
  Title
The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease.
  Journal
Clin Nutr 30:6-19 (2011)
DOI:10.1016/j.clnu.2010.06.001
Reference
  Authors
Hotamisligil GS
  Title
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.
  Journal
Cell 140:900-17 (2010)
DOI:10.1016/j.cell.2010.02.034
Reference
  Authors
Parekh S, Anania FA
  Title
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
  Journal
Gastroenterology 132:2191-207 (2007)
DOI:10.1053/j.gastro.2007.03.055
Reference
  Authors
Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ
  Title
JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
  Journal
Hepatology 43:163-72 (2006)
DOI:10.1002/hep.20999
Reference
  Authors
Leung TM, Nieto N
  Title
CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
  Journal
J Hepatol 58:395-8 (2013)
DOI:10.1016/j.jhep.2012.08.018
Reference
  Authors
Zafrani ES
  Title
Non-alcoholic fatty liver disease: an emerging pathological spectrum.
  Journal
Virchows Arch 444:3-12 (2004)
DOI:10.1007/s00428-003-0943-7
Reference
  Authors
Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ
  Title
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.
  Journal
Gastroenterology 125:437-43 (2003)
DOI:10.1016/S0016-5085(03)00907-7
Reference
  Authors
Begriche K, Igoudjil A, Pessayre D, Fromenty B
  Title
Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.
  Journal
Mitochondrion 6:1-28 (2006)
DOI:10.1016/j.mito.2005.10.004
Reference
PMID:9285483
  Authors
Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G
  Title
The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.
  Journal
FASEB J 11:851-7 (1997)
DOI:10.1096/fasebj.11.11.9285483
Reference
  Authors
Malhi H, Kaufman RJ
  Title
Endoplasmic reticulum stress in liver disease.
  Journal
J Hepatol 54:795-809 (2011)
DOI:10.1016/j.jhep.2010.11.005
Reference
  Authors
Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM
  Title
Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.
  Journal
Free Radic Biol Med 44:1259-72 (2008)
DOI:10.1016/j.freeradbiomed.2007.12.029
Reference
  Authors
Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E
  Title
Mitochondrial involvement in non-alcoholic steatohepatitis.
  Journal
Mol Aspects Med 29:22-35 (2008)
DOI:10.1016/j.mam.2007.09.014
Reference
  Authors
Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B
  Title
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
  Journal
Hepatology 58:1497-507 (2013)
DOI:10.1002/hep.26226
Related
pathway
btax00061  Fatty acid biosynthesis
btax00190  Oxidative phosphorylation
btax03320  PPAR signaling pathway
btax04141  Protein processing in endoplasmic reticulum
btax04151  PI3K-Akt signaling pathway
btax04210  Apoptosis
btax04668  TNF signaling pathway
btax04920  Adipocytokine signaling pathway
btax04930  Type II diabetes mellitus
KO pathway
ko04932   

DBGET integrated database retrieval system